Abstract
The usefulness of a new oral contraceptive compound containing norethindrone 5 mg. and mestranol 0.075 mg. (Ortho-Novum) was studied. One hundred and seventeen private patients used this preparation for a total of 998 menstrual cycles. There were no pregnancies. Side effects were minimal and caused few (11 patients) to discontinue use. The most significant of these was weight gain and a premenstrual tension syndrome including nausea, breakthrough bleeding and skin effects. Other symptoms were minor and easily controlled. Instruction in use of the preparation is easy. Patient acceptance is excellent. Possible masculinizing effects, liver damage, or harmful effects on the uterus were checked specifically by laboratory evaluation; no significant abnormal findings were noted.
This appears to be an effective oral contraceptive which is well accepted by the patient and which produced no serious side effects as used in this study.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DECOSTA E. J. Those deceptive contraceptives. JAMA. 1962 Jul 14;181:122–125. doi: 10.1001/jama.1962.03050280052005g. [DOI] [PubMed] [Google Scholar]
- DUNNING M. F. Jaundice associated with norethandrolone (Nilevar) administration. J Am Med Assoc. 1958 Jul 5;167(10):1242–1243. doi: 10.1001/jama.1958.72990270011009d. [DOI] [PubMed] [Google Scholar]
- Rice-wray E., Schulz-contreras M., Guerrero I., Aranda-rosell A. Long-term administration of norethindrone in fertility control. JAMA. 1962 May 5;180(5):355–358. [PubMed] [Google Scholar]
- SCHAFFNER F., POPPER H., CHESROW E. Cholestasis produced by the administration of norethandrolone. Am J Med. 1959 Feb;26(2):249–254. doi: 10.1016/0002-9343(59)90314-6. [DOI] [PubMed] [Google Scholar]
- WILDER E. M. Death due to liver failure following the use of methandrostenolone. Can Med Assoc J. 1962 Oct 6;87:768–769. [PMC free article] [PubMed] [Google Scholar]